Sorin’s innovative vascular peripheral products are used by vascular surgeons and interventional radiologists for the treatment of peripheral arterial disease. As part of its acquisition, Datascope has also received exclusive, worldwide rights to use the Carbofilm technology and other intellectual property within the endovascular field of use. The product line includes balloon-expandable and self-expanding stent systems, as well as balloon systems for use in percutaneous transluminal angioplasty.
With the acquisition, Datascope now gains the opportunity to market the product line throughout the world. Datascope estimates the worldwide market at $800 million annually, of which $200 million is in Europe, $500 million in the US and $40 million in Japan.
Antonino Laudani, COO of Datascope, said: “This acquisition opens great opportunities to expand sales to other large markets of the world. We look forward to integrating these new technologies, accelerating our product development and leveraging our capabilities in marketing, sales, clinical education and training.”